We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

InforSense and Ingenuity Systems Join Forces to Deliver Integrated Pathway Analysis Workflows

Listen with
Speechify
0:00
Register for free to listen to this article
Thank you. Listen to this article using the player above.

Want to listen to this article for FREE?

Complete the form below to unlock access to ALL audio articles.

Read time: 1 minute

InforSense Ltd has announced that it has partnered with Ingenuity Systems, a provider of software and databases for biological exploration, interpretation and analysis.

The partnership will provide integration capabilities between InforSense KDE and Ingenuity Pathway Analysis (IPA).

Ingenuity Systems has also joined the InforSense Open Workflow Partner Network.

The collaboration is made to allow customers, who have both InforSense KDE and IPA licenses, to build workflows incorporating newly available IPA nodes.

Customers will be able to use the IPA nodes as part of their existing and new KDE analysis workflows to enhance and expand their use of IPA.

The IPA functionality available through the KDE workflow allows data to be uploaded and analyzed automatically.

In addition, users can view gene and gene neighbor information generated from a KDE workflow. The nodes are available now through InforSense.

“The collaboration between InforSense and Ingenuity Systems will provide life science researchers with a streamlined way to perform robust analysis and quickly identify biological relationships that are most relevant to their research for optimized decision-making,” said Tuan Nguyen, VP, Partner and Professional Services of Ingenuity Systems.

“InforSense workflows enable life science researchers to seamlessly link to IPA pathway data and custom build their analyses in a visual environment.”

“Pathway analysis is a fundamental part of the research process in the life sciences, particularly within the pharmaceutical industry, and we are pleased to be working with Ingenuity in this area,” commented Dr. Jonathan Sheldon, Chief Scientific Officer, InforSense.

“Integrating the value, which Ingenuity Pathway Analysis already provides to researchers together with the InforSense Life Science platform, is proving to be a beneficial addition to our multidisciplinary analytic workflows.”